Somatic genetic alterations in synchronous and metachronous low‐grade serous tumours and high‐grade carcinomas of the adnexa. Issue 4 (15th January 2019)

• Record Type: Journal Article
• Authors: Murali, Rajmohan; Selenica, Pier; Brown, David N; Cheetham, R Keira; Chandramohan, Raghu; Claros, Nidia L; Bouvier, Nancy; Cheng, Donavan T; Soslow, Robert A; Weigelt, Britta; McCluggage, W Glenn
• Is Part Of: Histopathology. Volume 74:Issue 4(2019)
• Page Start: 638
• Page End: 650
• Publication Date: 2019-01-15
• Subjects: high‐grade serous carcinoma -- low‐grade serous carcinoma -- massively parallel sequencing -- molecular genetics -- ovary -- serous borderline tumour -- tumour progression; Histology, Pathological -- Periodicals; 611.018
• DOI: 10.1111/his.13796
• Languages: English
• ISSNs: 0309-0167

Abstract

Abstract : Aims: Low‐grade serous carcinomas (LGSCs) and their precursors serous borderline tumours (SBTs) characteristically harbour mutations in BRAF, KRAS or NRAS but rarely in TP53, whereas high‐grade serous carcinomas (HGSCs) are characterised by frequent TP53 mutations but rare BRAF, KRAS or NRAS mutations. In a small subset of cases, LGSCs and/or SBTs develop into high‐grade tumours, including HGSCs and poorly differentiated carcinomas (PDCs). Here, we sought to define the repertoire of somatic genetic alterations in low‐grade serous tumours and synchronous or metachronous high‐grade adnexal carcinomas. Methods and results: DNA extracted from five SBTs/LGSCs and synchronous or metachronous HGSCs/PDCs and matched normal tissue was subjected to massively parallel sequencing targeting all exons and selected non‐coding regions of 341 cancer‐related genes. The low‐grade and high‐grade tumours from a given case were related, and shared mutations and copy number alterations. Progression from low‐grade to high‐grade lesions was observed, and involved the acquisition of additional mutations and/or copy number alterations, or shifts from subclonal to clonal mutations. Only two (an HGSC and a PDC) of the five high‐grade tumours investigated harboured TP53 mutations, whereas NRAS and KRAS hotspot mutations were seen in two HGSCs and one HGSC, respectively. Conclusions: Our results suggest that progression from SBT to HGSC may take place in a subset of cases, and that at least some of the rare HGSCs lacking TP53 mutations may be derived from a low‐grade serous precursor.